Complexa Stock

complexarx.comHealthcareFounded: 1900Funding to Date: $91.54MM

Complexa is a clinical stage biopharmaceutical company focused on transforming the treatment of fibrosis and inflammatory diseases.

Register for Details

For more details on financing and valuation for Complexa, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Complexa.

Register Today

Team

Management Team

Meg Tarpey MD
Founding Scientist
Francisco Salva
Board Member, President & Chief Executive Officer
Bruce Freeman Ph.D
Co-Founder & Co-Founding Scientist
Theodore Danoff Ph.D
Chief Medical Officer
David Mott
Chairman of the Board of Directors
Joshua Tarnoff
Chief Executive Officer, President & Board Member
Raymond Miller JD
Co-Founder

Board Members

David Mott
Gilles Nob├ęcourt
Andera Partners
Kenji Harada Ph.D
Jafco
Barbara Dalton Ph.D
Pfizer Ventures
I. Wistar Morris III
Sara Nayeem MD
New Enterprise Associates
Bernardus Machielse
Joshua Tarnoff

Other companies like Complexa in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$1.08B
Sector
 
 

News

Complexa Inc. today announced the appointment of Theodore (Theo) Danoff, MD, PhD, as Chief Medical Officer. Dr. Danoff formerly served as Chief Medica